DNA gyrase
DNA Gyrase[edit | edit source]
DNA gyrase is a type II topoisomerase enzyme that plays a crucial role in DNA replication and transcription. It is found in bacteria and some archaea, and is responsible for introducing negative supercoils into DNA molecules. This process helps to relieve the torsional strain that builds up ahead of the replication fork or transcription bubble.
Structure[edit | edit source]
DNA gyrase is a tetrameric enzyme composed of two GyrA and two GyrB subunits. The GyrA subunit contains the DNA cleavage and rejoining activity, while the GyrB subunit possesses the ATPase activity required for the enzyme's function. The two subunits are connected by a flexible linker region, allowing for conformational changes during the catalytic cycle.
Mechanism of Action[edit | edit source]
DNA gyrase acts by introducing double-stranded breaks in the DNA molecule, allowing it to pass another segment of DNA through the break. This process involves the formation of a covalent intermediate between the enzyme and the DNA, known as a cleavage complex. The GyrA subunit cleaves one strand of the DNA, while the GyrB subunit passes the other strand through the break. Finally, the DNA is resealed, and the enzyme is released.
Function[edit | edit source]
DNA gyrase is essential for the proper functioning of DNA replication and transcription in bacteria. By introducing negative supercoils, it helps to maintain the correct DNA topology and prevent the formation of DNA knots and tangles. It also plays a role in the regulation of gene expression by modulating the accessibility of DNA to other proteins involved in transcription and replication.
Clinical Significance[edit | edit source]
DNA gyrase is an important target for antibiotics, such as fluoroquinolones. These drugs inhibit the ATPase activity of the GyrB subunit, preventing the enzyme from functioning properly. By interfering with DNA gyrase, antibiotics can disrupt DNA replication and transcription, leading to bacterial cell death. This makes DNA gyrase an attractive target for the development of new antimicrobial agents.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
